Announcement
Osirium Technologies : Contract win with major regional Ambulance Service
RNS Number : 3532G
Osirium Technologies PLC
17 March 2020
17 March 2020
RNS REACH
Osirium Technologies plc
("Osirium" or "Group")
Contract win with major regional Ambulance Service
Osirium Technologies plc (AIM: OSI.L), a leading vendor of cloud-based cybersecurity software, is pleased to announce a contract win with a major regional UK Ambulance Service.
The new client has purchased a 60 month term license for 250 devices for the Osirium PAM platform including the Privileged Access Management, Privileged Task Management and Privileged Session Management modules. Consultancy and training from Osirium Professional Services are included in the contract.
The Osirium PAM platform has been selected in a public sector tender bid as part of a sales initiative led jointly by Osirium and an approved reseller partner. The principal d rivers for the client on this project are securing and controlling access to the infrastructure by 3rd party contractors and vendors, implementing secure access for internal staff to privileged accounts, and managing service accounts in line with policy. The client will be making full use of Osirium Task Automation to 'Shift Left' or delegate IT tasks to junior IT team members and free up senior IT staff to focus on complex projects.
David Guyatt, Chief Executive Officer, commented : "I am delighted that, in addition to Osirium being selected as the specialist PAM provider for NHS Trusts, we and our reseller partners are now expanding our customer range to include the ambulance services sector. It is another illustration of the strength of Osirium functionality, in particular our task and process automation capabilities, combined with our UK presence and ease of deployment. These allow customers to automate key processes and securely delegate essential tasks in a way that drives real time and cost savings while ensuring maximum security."
- Ends -
For further information:
|
Osirium Technologies plc |
Tel: +44 (0) 118 324 2444 |
|
David Guyatt, Chief Executive Officer Rupert Hutton, Chief Financial Officer
|
|
|
Stifel Nicolaus Europe Limited (Nominated Adviser and Broker) |
Tel: +44 (0) 20 7710 7600 |
|
Fred Walsh / Neil Shah
|
|
|
Alma (Financial PR) Hilary Buchanan / Josh Royston / Kieran Breheny |
Tel: +44 (0) 203 405 0205
|
Notes to Editors:
Osirium Technologies plc (AIM: OSI) operates in one of the fastest growing parts of the cybersecurity market and is a leading vendor of Privileged Access Security solutions. Osirium's cloud-based products protect critical IT assets, infrastructure and devices by preventing targeted cyber-attacks from directly accessing Privileged Accounts, removing unnecessary access and powers of Privileged Account users, deterring legitimate Privileged Account users from abusing their roles and containing the effects of a breach if one does happen.
Osirium has defined and delivered what the Directors view as the next generation Privileged Access Management solution. Osirium's award-winning Privileged Task Management module further strengthens Privileged Account Security by minimising the cyber-attack surface and delivering an impressive return on investment benefits for customers. Building on Osirium's Privileged Task Management module, in May 2019 Osirium launched Privileged Process Automation, providing a highly-flexible platform for automating essential IT processes to set a new benchmark in IT Process Automation. This was followed by the launch of Privileged Endpoint Manager in December 2019, bringing the total portfolio to three complementary solutions.
Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to AIM in April 2016. For further information please visit www.osirium.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
NRAJFMFTMTIBBIM
;